Operator: Ladies and gentlemen, thank you for standing by. Welcome to Evogene s Third Quarter 2022 Results Conference Call. All participants are at present in listen-only mode.
/PRNewswire/ Canonic Ltd., focused on the development of medical grade cannabis products and a wholly owned subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE:.
/PRNewswire/ Canonic Ltd., focused on the development of medical-grade cannabis products and a wholly-owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE:.
/PRNewswire/ Canonic Ltd., focused on the development of medical-grade cannabis products and a wholly-owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE:.
/PRNewswire/ Canonic Ltd., focused on the development of medical grade cannabis products and a wholly-owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE:.